Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 MILLER RICHARD A MD President and CEO Buy 100,000 $3.50 $350,000 No
2019-11-13 MILLER RICHARD A MD President and CEO Buy 15,008 $3.00 $45,029 No
2019-08-07 MILLER RICHARD A MD President and CEO Buy 7,500 $3.56 $26,725 No
2019-06-14 MILLER RICHARD A MD President and CEO Buy 12,000 $3.41 $40,874 No
2019-06-11 MILLER RICHARD A MD President and CEO Buy 15,212 $3.49 $53,039 No
2018-12-27 MILLER RICHARD A MD President and CEO Buy 20,000 $3.29 $65,884 No
2018-12-20 MILLER RICHARD A MD President and CEO Buy 10,000 $4.39 $43,950 No
2018-12-06 MILLER RICHARD A MD President and CEO Buy 5,000 $5.99 $29,934 No
2018-12-04 MILLER RICHARD A MD President and CEO Buy 1,502 $5.95 $8,937 No
2018-03-12 MILLER RICHARD A MD President and CEO Buy 100,000 $8.50 $850,000 No
2017-11-20 MILLER RICHARD A MD President and CEO Buy 10,000 $10.79 $107,850 No
2017-06-13 MILLER RICHARD A MD President and CEO Buy 25,000 $9.88 $247,084 No
2016-05-13 MILLER RICHARD A MD President and CEO Buy 30,300 $10.00 $302,981 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.